We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

ERBA MANNHEIM

Erba Mannheim is an IVD solutions provider focused on improving health outcomes in developing nations. Originally fou... read more Featured Products: More products

Download Mobile App





Erba Mannheim Launches New Electrolyte Analyzer with Maintenance-free Electrodes at MEDLAB 2020

By LabMedica International staff writers
Posted on 05 Feb 2020
Erba Mannheim (London, UK) launched its new electrolyte analyzer, EC 90 with maintenance-free electrodes in an all-in-one sensor cartridge, at MEDLAB 2020. More...
Additionally, Erba launched new immunoassays, clinical chemistry, diabetes and hematology products designed to boost productivity of small and medium sized labs. The company also provided a preview of its NEXUS range of next generation total lab automation solutions.

The EC 90 directly measures Na+, Cl-, K+ and Ca2+ from whole blood, plasma, serum and pre-diluted urine using a sensor incorporating thick film technology. A "plug and play" sensor cartridge is integrated into a new reagent pack capable of performing up to 3,000 samples, with a market leading on-board lifetime of three months. No maintenance or cleaning of the pack is required, and waste is self-contained. The EC 90 can analyze samples in 35 seconds, with a typical throughput of 90 samples/hour, and has 35µL and 70µL sample volume measuring modes. Results can be given with a resolution of 0.1mmol/L for Na[+] and Cl-, 0.01mmol/L for K[+] and Ca[2+] and are reproducible with CV< 1%. Small and lightweight (337 x 273 x 422mm, < 8kg), the EC 90 comes with an 8.5-inch color touchscreen display, LIS connectivity, automatic calibration, two USB ports, on-board 24 column thermal printer and a serial port.

Alongside the EC 90, Erba launched the new HB715 automated desktop analyzer for measuring glycated hemoglobin (HbA1c, HbA1ab, HbA1c, HbF, HbA0, HbA2/E/D, HbS, HbC) and designed for ease of use and low-cost operation. Erba also launched its new ELAN 30s analyzer, a fully automated compact benchtop ELISA microstrip processor that can perform six different tests simultaneously, and Rapid Malaria and Dengue Tests with unique Dual Color Detection system. In hematology, the company launched the new ESL 30, a fully automated ESR testing solution that improves result quality, laboratory safety and efficiency in mid-sized labs at an affordable price. Alongside the new products, Erba presented the updated versions of its signature XL 200 and XL 640+ clinical chemistry analyzers.

Additionally, Erba provided a preview of its next generation NEXUS total lab automation system which will offer powerful, modular solutions using advanced imaging and artificial intelligence. The NEXUS IA immunoassay analyzer uses unique magnetic CLIA bead technology and extensive panels to deliver a reliable and affordable solution, while the Nexus H Infinity Hematology analyzer uses computer vision to actually 'see' the sample and provides advanced diagnostics by counting, staining, imaging and analyzing 1000's of cells in less than a minute.

"At MEDLAB ME, we continue to demonstrate our commitment to becoming a leading player in the IVD market. With NEXUS we offer a unique entry level system for Total Lab Automation, enabling labs to scale their business with higher automation. Also, by significantly strengthening our product portfolio for small and medium sized labs and growing our global customer base, we are well placed to achieve our ambition," said Romain Fournials, CCO of Erba Mannheim.

Related Links:
Erba Mannheim


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
New
PSA Assay
CanAg PSA EIA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.